{
    "title": "111_hr4390",
    "content": "The Act is titled the \"Medicare and Medicaid Fraud Prevention and Control Act of 2009.\" It introduces enhanced program and provider protections in the Medicare, Medicaid, and CHIP programs. The \"Medicare and Medicaid Fraud Prevention and Control Act of 2009\" authorizes enhanced oversight measures for providers at risk of fraudulent activity based on various sources of information. The \"Medicare and Medicaid Fraud Prevention and Control Act of 2009\" allows the Secretary to impose requirements on providers or suppliers enrolling or renewing in Medicare, Medicaid, or CHIP programs, including screening, enhanced oversight periods, enrollment moratoria, and periodic validations. The \"Medicare and Medicaid Fraud Prevention and Control Act of 2009\" authorizes the Secretary to impose requirements on providers enrolling in Medicare, Medicaid, or CHIP programs, including screening, enhanced oversight periods, enrollment moratoria, and periodic validations. The Secretary may also require states to implement these provisions as part of their state plans. Actions and determinations under these provisions are not subject to review. The Secretary can impose requirements on providers enrolling in Medicare, Medicaid, or CHIP programs, including screening procedures like licensing board checks, background checks, and screening against exclusion lists. Actions and determinations made under these provisions are not reviewable by a judicial tribunal. The Secretary can impose requirements on providers enrolling in Medicare, Medicaid, or CHIP programs, including screening procedures like licensing board checks, background checks, and screening against exclusion lists. Providers may also be subject to enhanced oversight for a period of 30 to 365 days, including unannounced site visits. The Secretary can impose enhanced oversight on providers for a period of 30 to 365 days, including site visits, inspections, and review of claims, to address fraudulent activity among suppliers. The Secretary can impose enhanced oversight on suppliers of durable medical equipment for a specified period if there is a significant risk of fraudulent activity, withholding payment for equipment furnished during that time. The Secretary can withhold payment for durable medical equipment supplied by a supplier if there is a risk of fraudulent activity, and establish a program for periodic review of physician authorizations for excessive prescribing. The Secretary can withhold payment for durable medical equipment supplied by a supplier if there is a risk of fraudulent activity. Additionally, a program can be established for periodic review of physician authorizations for excessive prescribing, where the physician or professional must validate claims within a 90-day period. The Secretary may impose a moratorium on provider enrollment in certain cases of ongoing fraud within Medicare, Medicaid, or CHIP programs. This is to ensure the legitimacy of claims for items and services prescribed by physicians or professionals. The Secretary may impose a moratorium on provider enrollment in cases of ongoing fraud within Medicare, Medicaid, or CHIP programs to ensure legitimacy of claims. States can engage in additional provider screening activities beyond those required by the Secretary. The Secretary can impose a probationary period for new providers to undergo heightened review for legitimacy. This period includes random claims sampling and validation by the Secretary or a contractor. The Secretary may impose a probationary period for new providers to undergo heightened review, including random claims sampling and validation of physician prescriptions. If a significant number of claims are found to be illegitimate, the Secretary can suspend or terminate the provider's participation. If a significant number of claims are deemed illegitimate, the Secretary can suspend or terminate the provider's participation, with the possibility of imposing a civil monetary penalty for non-cooperation in prescription validation. The provisions of section 1128A apply to these actions. The Secretary may impose a civil monetary penalty of up to $10,000 on providers or suppliers who fail to cooperate in prescription validation. Section 1128A provisions apply to these penalties. Amendments are made to Prompt Pay Provisions in sections 1816(c)(2) and 1842(c)(2) of the Act. Amendments are made to sections 1816(c)(2) and 1842(c)(2) of the Act regarding contract requirements for providers and suppliers. A new subparagraph is added to address suspicious claim submissions. Conforming amendments are also made to Section 1902(a) of the Social Security Act related to Medicaid. Amendments to Section 1902(a) of the Social Security Act under Medicaid include enforcing determinations made by the Secretary regarding fraudulent activity. Amendments to Section 2102 of the Social Security Act require States to enforce determinations made by the Secretary regarding fraudulent activity in the CHIP program. Amendments to Section 2102 of the Social Security Act mandate that States enforce Secretary determinations on fraudulent activity in the CHIP program. The State must also carry out activities as required by the Secretary for program integrity. The amendments made to the Social Security Act require States to enforce Secretary determinations on fraudulent activity in the CHIP program. Providers and suppliers must comply with program integrity provisions outlined in section 1128G. The Secretary of Health and Human Services consults with the Inspector General to identify providers and suppliers at risk of fraudulent activity under Medicare, Medicaid, or CHIP. Additional funding is authorized for implementation. The Secretary of Health and Human Services consults with the Inspector General to identify providers and suppliers at risk of fraudulent activity under Medicare, Medicaid, or CHIP. Additional funding is authorized for implementation to address fraud and abuse in specific geographic areas. The amendments made by this section shall take effect upon the date of the enactment of this Act, with regulations to be promulgated by the Secretary of Health and Human Services within 6 months for expedited implementation. The Secretary shall promulgate regulations within 6 months of the Act's enactment, with interim final regulations becoming effective immediately upon publication. Public comments will be allowed, and the Secretary may make changes based on feedback."
}